News Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer Continue Reading Previous APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF)Next EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023 Related Stories News WEEX Burns $2 Million WXT, 0.61% of the Total Supply News ‘Waste-to-Value, Industry Upgrade, and GBA Co-Creation’ Technology Forum Brings Together Top Experts, Driving Green Industry Advancement Through Frontier Technologies News Imagen Network Uses Grok Intelligence to Improve Real Time Personalization in Social Apps News Michael Owen Becomes the New Face of GK8: Fastest Growing iGaming Brand News Risetcar’s driverless taxis are performing well in the US, with Jakarta operations set to launch soon News CAST announces early access to CAST Imaging MCP server
